cancer clinical trials for Myeloma/Plasma Cell Dyscrasia (ONC)

8 Myeloma/Plasma Cell Dyscrasia (ONC) clinical trials found. View a list of all cancer clinical trial types.

• A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (CCS1477-04)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase II Randomized Trial of Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation (ENABLE-1)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase II, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma

  Current Status: Open

  View links and contact information related to this clinical trial

• Intermediate-Size Population Expanded Access Program (EAP) for cilta-cel Out-of-Specification (OOS) in Patients with Multiple Myeloma

  Current Status: Open

  View links and contact information related to this clinical trial

• Cognition in older adults with myeloma undergoing CAR-T therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I Multicenter, Open-Label Study to Determine the Recommended Dose and Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants with Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose For Each Add On Investigational Component

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients with Newly Diagnosed AL Amyloidosis

  Current Status: Open

  View links and contact information related to this clinical trial

• An Observational Study Associating Adiponectin Signaling with Acute and Chronic Toxicity Following Pelvic Radiation

  Current Status: Open

  View links and contact information related to this clinical trial